
    
      Prospective study. All patients who participated ELVIS study (clinical trials: 00875069) can
      be enrolled in SURIA.

      Patients are contacted by telephone. Investigator delivery objective and honest information.
      If patients accepts the study, answers will be collected.

      Collected data are: creatinine serum, two surveys (quality of life and activities of daily
      living), date of onset of renal replacement therapy.
    
  